Archives
-
TBXA2R–ERM Signaling in TNBC Metastasis
2026-09-23
The reference study identifies TBXA2R as an upstream GPCR that activates ERM proteins through Gαq/11, Gα12/13, Rho GTPases, and the SLK/LOK kinase network. This signaling axis links receptor activity to triple-negative breast cancer motility, invasion, and metastatic colonization, providing a mechanistic framework for studying cytoskeletal control of metastasis.
-
Chlorpromazine C6410 for Reliable Cell Assays
2026-09-22
Learn how Chlorpromazine (SKU C6410) can support more reproducible cell viability, proliferation, cytotoxicity, and nanoparticle-interaction workflows. This scenario-based guide covers solvent controls, dose preparation, interpretation, hepatic cell heterogeneity, and practical vendor-selection criteria.
-
Ranolazine Beyond Ischemia: A TBK1 Test
2026-09-22
Ranolazine offers more than a conventional cardiac ischemia research tool. Its late sodium current inhibition, metabolic actions, and potential utility in mechanism-separating assays create a translational framework for testing how energetic state intersects with TBK1, interferon, and autophagy biology in HBV models—without overstating evidence that does not yet exist.
-
HNRNPU K181 Lactylation Rewires Cervical Cancer
2026-09-21
The reference study identifies HNRNPU lactylation as a lactate-responsive mechanism that stabilizes PHGDH expression and redirects serine metabolism in cervical cancer. Its findings connect a non-histone post-translational modification to RNA regulation, redox balance, nucleotide production, and tumor growth, while also highlighting pharmacological and experimental questions for follow-up studies.
-
4-Phenylbutyric acid: ER Stress Workflow
2026-09-21
Build stronger ER-stress causality experiments with 4-Phenylbutyric acid, from stock preparation through orthogonal viability, signaling, and autophagy readouts. This workflow translates a liver-cancer study into practical assay controls for distinguishing ER stress-mediated cytotoxic autophagy from apoptosis or nonspecific toxicity.
-
GPR35–KLF5 Circuitry in Colonic Repair
2026-09-20
The reference study identifies a tryptophan–kynurenine–kynurenic acid sensing mechanism in which GPR35 converts mucosal damage signals into KLF5-dependent epithelial repair. Its findings connect metabolite surveillance with PI3K–AKT–mTOR signaling and provide a mechanistic framework for interpreting barrier restoration in ulcerative colitis research and DSS-based models.
-
PPT: A Decision Framework for ERα Assays
2026-09-19
PPT (Propyl Pyrazole Triol) enables precise interrogation of ERα biology without treating receptor activation and cancer-network correlation as equivalent evidence. This article translates a female lung adenocarcinoma biomarker study into practical assay decisions, controls, and interpretation strategies.
-
Miransertib and WecA: Designing Clear Assays
2026-09-18
Miransertib is best used as an orthogonal AKT-pathway research probe, not as a presumed WecA inhibitor. This article explains how the latest WecA purification and kinetic framework can sharpen target-validation decisions, controls, and assay interpretation.
-
IPR-803: Urokinase Receptor Inhibitor Workflow
2026-09-18
IPR-803 is a competitive uPAR inhibitor for dissecting uPAR–uPA signaling, tumor invasion, and angiogenesis in breast and pancreatic cancer models. This workflow connects biochemical target engagement with invasion assays and the stromal-remodeling strategy reported for gemcitabine delivery in pancreatic cancer.
-
Clozapine N-oxide (CNO) for Circuit Studies
2026-09-17
Clozapine N-oxide (CNO) converts engineered receptor expression into reversible, non-invasive neuronal activity modulation. This workflow-focused guide shows how to use CNO in light–anxiety circuit studies, manage ligand preparation, and separate receptor-mediated effects from timing, handling, and behavioral confounds.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-17
Cy5 NHS ester(Et) provides a water-compatible way to covalently tag primary amines on proteins, peptides, and related biomolecules for fluorescent detection. It is appropriate for aqueous or DMSO-based labeling workflows, but not for ethanol-based preparation or long-term storage of dissolved reagent.
-
Chlorpromazine Workflows for Cellular Research
2026-09-16
Build reproducible dopamine D2 receptor signaling, antipsychotic, and antiemetic assays with chlorpromazine hydrochloride while controlling solvent, timing, and cell-context effects. A recent hepatic nanoparticle study adds a practical lesson: cellular heterogeneity and physicochemical context should guide assay design rather than relying on a single presumed clearance pathway.
-
Chlorpromazine in Neuropharmacology Assays
2026-09-16
Chlorpromazine and chlorpromazine hydrochloride support precise studies of dopamine D2 receptor signaling, antipsychotic pharmacology, and emesis pathways. This guide adds a distinct assay-design perspective by showing how recent liver nanoparticle research can sharpen compartment-specific experimental interpretation without overstating cross-domain evidence.
-
H 89 2HCl in Hippocampal PKA Assays
2026-09-15
H 89 2HCl is a selective PKA probe for dissecting cAMP/PKA signaling, protein phosphorylation, and neuronal calcium regulation. This guide connects its pharmacology to glucocorticoid-driven Kv2.1–CaV1.2 trafficking and outlines controls that distinguish PKA causality from concentration-dependent off-target effects.
-
Rhodamine B: From Spray Drift to Signal Quality
2026-09-15
Rhodamine B is more than a fluorescent tracer: it is a measurement tool for connecting spray deposition, matrix effects, and assay quality. This article explains how to use Basic Violet 10 to design better drift studies and interpret fluorescence responsibly across environmental and imaging workflows.